Mar 19, 2026
Mar 19, 2026
Mar 19, 2026
Mar 19, 2026
Mar 19, 2026
Mar 19, 2026
Mar 19, 2026
Mar 19, 2026
19 days ago
The ROTOR Act promised to enhance cockpit safety with ADS-B In technology, but cost concerns killed it in the House. As safety debates rage, pilots and passengers are left in a precarious position.
19 days ago
Teva Pharmaceuticals banks on generics after patents expire, but is the strategy running out of steam? We explore the risks and rewards.
19 days ago
Teva Pharmaceuticals is eyeing a big opportunity in the generic drugs market, but is it really a win for investors? We break down the potential and the pitfalls.